3rd Quarter - Report

CENCORA, INC. for CENCORA, INC.

Firm
Client
Income
—
Expenses
$680,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

One Big Beautiful Bill Act/Budget Reconciliation (H.R.1) Tariff proposed policies LIFO accounting method Global Intangible Low-taxed Income (GILTI)

LobbyistCovered position, as disclosed
VIVIENNE STAFFORD MITCHELL —
SHELLY MUI-LIPNIK —
DARRELL ROGERS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1 (119th)

Medicare/Medicaid MMM

Ensuring Community Access to Pharmacist Services Act (H.R. 3164)/Equitable Community Access to Pharmacist Services Act (S.2426) Inflation Reduction Act implementation, including impact on Pharmacy & Physician Reimbursement Extend payment increase under Medicare's physician fee schedule. Medicare Access & CHIP Reauthorization Act (MACRA). CMS Proposed Medicare Physician Fee Schedule Rule Protecting Patient Access to Cancer and Complex Therapies Act 2025 Reimbursement policies impacting drug shortages Part B drug pricing changes Enhanced Oncology Model (EOM) Preventing and Mitigating Generic Drug Shortages

LobbyistCovered position, as disclosed
VIVIENNE STAFFORD MITCHELL —
SHELLY MUI-LIPNIK —
DARRELL ROGERS —

Contacted: White House Office; SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 2426 (119th), H.R. 3164 (119th)

Pharmacy PHA

Preventing and Mitigating Generic Drug Shortages Ensuring Seniors Access to Critical Medications Act (H.R. 3164)/Equitable Community Access to Pharmacist Services Act (S.2426)- Impacts to pharmacy Part D drug pricing in Inflation Reduction Act (IRA)

LobbyistCovered position, as disclosed
VIVIENNE STAFFORD MITCHELL —
SHELLY MUI-LIPNIK —
DARRELL ROGERS —

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; White House Office; HOUSE OF REPRESENTATIVES

Bills named: S. 2426 (119th), H.R. 3164 (119th)

Health Issues HCR

Strategic National Stockpile. Essential Medicines Strategic Stockpile Prescription Information Modernization Act (H.R.4132/S.2027) Mitigation of Drug Shortages Pandemic and All Hazards Preparedness Reauthorization and Response Act (legislation). SUPPORT for Patients and Communities Reauthorization Act of 2025 (H.R. 2483/S.2121) Medical Supply Resiliency Act National Defense Authorization Act FY2026 (NDAA) Supply Chain Resiliency Most Favored Nation drug pricing proposals One Big Beautiful Bill Act / Budget Reconciliation (H.R.1) CMS Proposed Medicare Physician Fee Schedule Rule

LobbyistCovered position, as disclosed
VIVIENNE STAFFORD MITCHELL —
SHELLY MUI-LIPNIK —
DARRELL ROGERS —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; White House Office; Food & Drug Administration (FDA); SENATE

Bills named: S. 2027 (119th), S. 2121 (119th), H.R. 2483 (119th), H.R. 4132 (119th), H.R. 1 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.